ATE348602T1 - Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung - Google Patents

Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Info

Publication number: ATE348602T1
Authority: AT; Austria
Prior art keywords: nanoparticles; active ingredients; administration; producing; particles
Prior art date: 2002-07-19

Application number

AT03765124T

Other languages

English (en)

Inventor

Fernandez Maria Jose Fa Alonso

Sur

Lopez Carmen Remunan

Vilan Margarita Maria Cuna

Sande Maria Alonso

Jato Jose Luis Vila

Original Assignee

Advancell Advanced In Vitro Ce

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-19

Filing date

2003-07-16

Publication date

2007-01-15

2003-07-16 Application filed by Advancell Advanced In Vitro Ce filed Critical Advancell Advanced In Vitro Ce

2007-01-15 Application granted granted Critical

2007-01-15 Publication of ATE348602T1 publication Critical patent/ATE348602T1/de

Links

239000002105 nanoparticle Substances 0.000 title abstract 5
239000004480 active ingredient Substances 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
239000002245 particle Substances 0.000 title 1
LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 abstract 1
229920001661 Chitosan Polymers 0.000 abstract 1
229920002581 Glucomannan Polymers 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
229940046240 glucomannan Drugs 0.000 abstract 1
235000019832 sodium triphosphate Nutrition 0.000 abstract 1
UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical group [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT03765124T 2002-07-19 2003-07-16 Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung ATE348602T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200201694A ES2221530B1 (es)	2002-07-19	2002-07-19	Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.

Publications (1)

Publication Number	Publication Date
ATE348602T1 true ATE348602T1 (de)	2007-01-15

Family

ID=30470576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03765124T ATE348602T1 (de)	2002-07-19	2003-07-16	Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Country Status (11)

Country	Link
US (1)	US20060134785A1 (de)
EP (1)	EP1561460B1 (de)
AT (1)	ATE348602T1 (de)
CA (1)	CA2492995A1 (de)
CY (1)	CY1106361T1 (de)
DE (1)	DE60310605T2 (de)
DK (1)	DK1561460T3 (de)
ES (2)	ES2221530B1 (de)
PT (1)	PT1561460E (de)
SI (1)	SI1561460T1 (de)
WO (1)	WO2004009060A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2226567B1 (es) *	2003-06-20	2006-07-01	Universidad De Santiago De Compostela	Nanoparticulas de acido hialuronico.
ES2246695B1 (es) *	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es)	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Nanoparticulas pegiladas.
WO2007036946A1 (en) *	2005-09-28	2007-04-05	Padma Venkitachalam Devarajan	Compositions for enhanced absorption of biologically active agents
EP1774971A1 (de) *	2005-10-14	2007-04-18	Advanced in Vitro Cell Technologies, S.L.	Nanopartikel enthaltend Chitosan und Heparin
US20110135742A1 (en) *	2006-06-20	2011-06-09	The Regents Of The University Of California	Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US9173852B2 (en) *	2008-04-08	2015-11-03	Tian Si Polymer Materials Technology Development Co.	Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
JP5804453B2 (ja) *	2009-05-14	2015-11-04	国立大学法人東京大学	結晶性ポリオール微粒子及びその調製方法
CA2767443A1 (en) *	2009-07-09	2011-01-13	Polymers Crc Limited	Biopolymer hybrid gel-depot delivery system
DE102009048553A1 (de)	2009-09-29	2011-03-31	Carl Zeiss Smt Gmbh	Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren
US8802076B2 (en)	2010-10-04	2014-08-12	Duke University	Compositions and methods for modulating an immune response
JP5903250B2 (ja) *	2011-11-16	2016-04-13	清水化学株式会社	徐放性組成物
KR101372834B1 (ko) *	2011-12-12	2014-03-14	전북대학교산학협력단	하이드로겔 버블 및 이의 제조방법
US9114091B2 (en) *	2013-07-05	2015-08-25	Shimizu Chemical Corporation	Sustained release solid dosage preparations
CN107970228A (zh) *	2017-11-02	2018-05-01	天津大学	一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法
CN111420067B (zh) *	2020-03-09	2021-08-27	西南交通大学	一种复合微球纳米载体及其制备方法和应用
WO2021209493A2 (en) *	2020-04-15	2021-10-21	Solyplus Gmbh	Means and methods of preventing and treating infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688422A1 (fr) *	1992-03-11	1993-09-17	Coletica	Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
ES2114502B1 (es) *	1996-07-29	1999-07-01	Univ Santiago Compostela	Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.

2002
- 2002-07-19 ES ES200201694A patent/ES2221530B1/es not_active Expired - Fee Related
2003
- 2003-07-16 EP EP03765124A patent/EP1561460B1/de not_active Expired - Lifetime
- 2003-07-16 US US10/521,382 patent/US20060134785A1/en not_active Abandoned
- 2003-07-16 DK DK03765124T patent/DK1561460T3/da active
- 2003-07-16 SI SI200330701T patent/SI1561460T1/sl unknown
- 2003-07-16 CA CA002492995A patent/CA2492995A1/en not_active Abandoned
- 2003-07-16 DE DE60310605T patent/DE60310605T2/de not_active Expired - Fee Related
- 2003-07-16 AT AT03765124T patent/ATE348602T1/de not_active IP Right Cessation
- 2003-07-16 WO PCT/ES2003/000372 patent/WO2004009060A1/es active IP Right Grant
- 2003-07-16 ES ES03765124T patent/ES2279172T3/es not_active Expired - Lifetime
- 2003-07-16 PT PT03765124T patent/PT1561460E/pt unknown
2007
- 2007-03-08 CY CY20071100323T patent/CY1106361T1/el unknown

Also Published As

Publication number	Publication date
DK1561460T3 (da)	2007-04-30
US20060134785A1 (en)	2006-06-22
SI1561460T1 (sl)	2007-06-30
DE60310605D1 (de)	2007-02-01
ES2279172T3 (es)	2007-08-16
ES2221530B1 (es)	2006-02-16
CA2492995A1 (en)	2004-01-29
WO2004009060A1 (es)	2004-01-29
EP1561460B1 (de)	2006-12-20
CY1106361T1 (el)	2011-10-12
ES2221530A1 (es)	2004-12-16
DE60310605T2 (de)	2007-09-27
PT1561460E (pt)	2007-03-30
EP1561460A1 (de)	2005-08-10

Similar Documents

Publication	Publication Date	Title
ATE348602T1 (de)	2007-01-15	Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung
BRPI0519195A2 (pt)	2008-12-30	composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
ATE396967T1 (de)	2008-06-15	(5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DK1429731T3 (da)	2007-05-14	Nanopartikelformuleringer indeholdende insulin
ATE536855T1 (de)	2011-12-15	Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
ATE355065T1 (de)	2006-03-15	Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
BR0008590A (pt)	2001-10-30	Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
DK1553927T3 (da)	2011-01-31	Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
ATE399553T1 (de)	2008-07-15	Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
WO2005020928A3 (en)	2005-04-21	Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
ATE466585T1 (de)	2010-05-15	Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
Rathi et al.	2017	Comparative evaluation of Nano-Hydroxyapatite preparation and Calcium Sucrose Phosphate on microhardness of deciduous teeth after iron drop exposure-An in-vitro study
HUP0303838A2 (hu)	2004-03-01	Eritropoietin mérsékli a kemoterápia-indukált toxicitást in vivo
WO2004067027A3 (en)	2004-09-16	Osteogenic composition
BRPI0417415A (pt)	2007-04-10	composições comestìveis que estão adaptadas para uso por um animal de estimação
ATE445409T1 (de)	2009-10-15	Zusammensetzungen mit matrixproteinen zur regeneration von dentin
RS50148B (sr)	2009-05-06	Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
KR20160096890A (ko)	2016-08-17	젤 형태의 모델링 마스크 팩 화장료 조성물
BG105275A (en)	2001-11-30	Tan-1057 derivatives
MXPA04001328A (es)	2004-05-05	Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
DE602006010111D1 (de)	2009-12-10	Pharmazeutische formulierung zur behandlung von osteoarthritis mit clodronsäure und hyaluronsäure
ATE404192T1 (de)	2008-08-15	Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
ATE548048T1 (de)	2012-03-15	Oncomodulin zur behandlung von neurologishen erkrankungen
HUP0500642A2 (hu)	2005-11-28	Csökkentett toxicitású ciszplatin készítmények és eljárás alkalmazásukra
RU2006109966A (ru)	2007-10-10	Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных

Legal Events

Date

Code

Title

Description

2007-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1561460

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee